TLV | 15 min of OLV | 30 min of OLV | 45 min of OLV | 60 min of OLV | |
---|---|---|---|---|---|
Desflurane group (n = 52) | |||||
End-tidal desflurane (vol%) | 5.4 ± 1.0 | 6.2 ± 0.8 | 6.2 ± 0.8 | 6.2 ± 0.8 | 6.2 ± 0.8 |
Minimum alveolar concentration | 1.0 ± 0.2 | 1.1 ± 0.2 | 1.1 ± 0.2 | 1.1 ± 0.1 | 1.1 ± 0.2 |
Ce, remifentanil (ng/ml) | 2.3 ± 1.1 | 2.4 ± 0.9* | 2.1 ± 1.1* | 1.9 ± 1.0* | 1.8 ± 1.0* |
MAP (mmHg) | 84 ± 13 | 85 ± 15 | 78 ± 12* | 75 ± 12* | 78 ± 9* |
HR (beats/min) | 68 ± 13 | 67 ± 11 | 70 ± 11 | 68 ± 10 | 69 ± 12 |
BT (°C) | 36.1 ± 0.4 | 36.1 ± 0.4 | 36.0 ± 0.4 | 35.9 ± 0.4 | 35.8 ± 0.5 |
CVP (mmHg) | 7 ± 3 | 8 ± 3 | 7 ± 3 | 7 ± 3 | 7 ± 3 |
CI (l/min/m2) | 2.7 ± 0.6 | 2.6 ± 0.6 | 2.9 ± 0.7 | 2.9 ± 0.7 | 2.9 ± 0.7 |
Ppeak (cmH2O) | 19 ± 2 | 22 ± 3 | 23 ± 4 | 23 ± 3 | 23 ± 3 |
PaCO2 (mmHg) | 41 ± 4 | 45 ± 5 | 45 ± 4 | 45 ± 4 | 45 ± 5 |
Arterial blood pH | 7.4 ± 0.0 | 7.4 ± 0.0 | 7.4 ± 0.0 | 7.4 ± 0.0 | 7.4 ± 0.0 |
Base excess (mmol/l) | 2.1 ± 2.2 | 1.9 ± 2.1 | 1.5 ± 2.2 | 1.6 ± 2.0 | 1.5 ± 2.1 |
Propofol group (n = 51) | |||||
Ce, propofol (μg/ml) | 3.6 ± 0.6 | 3.6 ± 0.6 | 3.5 ± 0.5 | 3.5 ± 0.5 | 3.6 ± 0.5 |
Ce, remifentanil (ng/ml) | 2.5 ± 1.2 | 3.0 ± 1.3* | 3.1 ± 1.3* | 3.2 ± 1.1* | 3.3 ± 1.1* |
MAP (mmHg) | 82 ± 13 | 85 ± 13 | 84 ± 10* | 81 ± 10* | 83 ± 10* |
HR (beats/min) | 64 ± 11 | 65 ± 12 | 68 ± 12 | 65 ± 11 | 65 ± 11 |
BT (°C) | 36.0 ± 0.4 | 35.9 ± 0.4 | 35.9 ± 0.4 | 35.8 ± 0.4 | 35.8 ± 0.4 |
CVP (mmHg) | 6 ± 3 | 7 ± 3 | 7 ± 3 | 7 ± 4 | 7 ± 3 |
CI (l/min/m) | 2.6 ± 0.7 | 2.7 ± 0.7 | 2.8 ± 0.9 | 2.8 ± 0.8 | 2.9 ± 0.8 |
Ppeak (cmH2O) | 19 ± 2 | 21 ± 3 | 23 ± 3 | 23 ± 3 | 23 ± 3 |
PaCO2 (mmHg) | 42 ± 5 | 44 ± 5 | 45 ± 5 | 44 ± 5 | 44 ± 5 |
Arterial blood pH | 7.4 ± 0.0 | 7.4 ± 0.0 | 7.4 ± 0.0 | 7.4 ± 0.0 | 7.4 ± 0.0 |
Base excess (mmol/l) | 2.5 ± 1.9 | 2.3 ± 2.0 | 2.2 ± 2.0 | 2.0 ± 2.0 | 2.0 ± 1.9 |